A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...

Investigational drug SPN-820, which activates the mTORC1 pathway, failed to significantly reduce depressive symptoms compared ...

Now, new research from the Warren Center for Neuroscience Drug Discovery (WCNDD) offers hope. Scientists have identified a ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

For around 70 years, the treatment of schizophrenia has relied almost entirely on drugs that block dopamine D2 receptors, but KarXT is one of a clutch of new therapies emerging from the pharma ...

Upheaval within the brain’s higher order networks could explain psilocybin users’ feelings of profound connection to the ...

the treatment of schizophrenia has relied almost entirely on drugs that block dopamine D2 receptors, but NBI-1117568 is one of a series of new therapies emerging from the pharma industry pipeline ...

Obesity is more than just a diet and exercise issue; it's deeply intertwined with psychological and social factors. Experts ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Hyperfocus is an intense, single-minded concentration on one task or activity. Find out what it looks like and how to manage ...